Hyperphosphatemia in chronic kidney disease
Hyperphosphatemia in renal pathology is a key factor for developing mineral and bone disorders. It can develop even in the early stages of renal function decline and predict the formation of vascular calcification and an increased risk for developing cardiovascular complications in patients with chr...
Main Authors: | S. A. Martynov, M. Sh. Shamkhalova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/3856 |
Similar Items
-
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches
by: Ajeeta Anand, et al.
Published: (2023-05-01) -
Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review
by: Steven N. Fishbane, et al.
Published: (2021-11-01) -
Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis
by: Pablo Molina, et al.
Published: (2023-12-01) -
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
by: N A Mukhin, et al.
Published: (2016-04-01) -
Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01)